Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Glycemic control in patients with insulinoma treated with everolimus.

× No keyword cloud information.

53 in total

Review 1. Clinical pathways for pancreatic neuroendocrine tumors.

Authors: Angela Alistar; Max Sung; Michelle Kim; Randall F Holcombe
Journal: J Gastrointest Cancer Date: 2012-12

2. NANETS treatment guidelines: well-differentiated neuroendocrine tumors of the stomach and pancreas.

Authors: Matthew H Kulke; Lowell B Anthony; David L Bushnell; Wouter W de Herder; Stanley J Goldsmith; David S Klimstra; Stephen J Marx; Janice L Pasieka; Rodney F Pommier; James C Yao; Robert T Jensen
Journal: Pancreas Date: 2010-08 Impact factor: 3.327

3. The use of targeted therapies in pancreatic neuroendocrine tumours: patient assessment, treatment administration, and management of adverse events.

Authors: Meredith Cummins; Nick Pavlakis
Journal: Ther Adv Med Oncol Date: 2013-09 Impact factor: 8.168

Review 4. Everolimus as first line therapy for pancreatic neuroendocrine tumours: current knowledge and future perspectives.

Authors: Marco Gallo; Pasqualino Malandrino; Giuseppe Fanciulli; Francesca Rota; Antongiulio Faggiano; Annamaria Colao
Journal: J Cancer Res Clin Oncol Date: 2017-04-12 Impact factor: 4.553

Review 5. Treatment of symptomatic neuroendocrine tumor syndromes: recent advances and controversies.

Authors: Tetsuhide Ito; Lingaku Lee; Robert T Jensen
Journal: Expert Opin Pharmacother Date: 2016-09-23 Impact factor: 3.889

Review 6. The functioning side of the pancreas: a review on insulinomas.

Authors: I Maggio; V Mollica; N Brighi; G Lamberti; L Manuzzi; A D Ricci; D Campana
Journal: J Endocrinol Invest Date: 2019-07-31 Impact factor: 4.256

7. Everolimus in the treatment of neuroendocrine tumors: efficacy, side-effects, resistance, and factors affecting its place in the treatment sequence.

Authors: Lingaku Lee; Tetsuhide Ito; Robert T Jensen
Journal: Expert Opin Pharmacother Date: 2018-05-24 Impact factor: 3.889

Glycemic control in patients with insulinoma treated with everolimus.